Benzylpenicillin Potassium

青霉素钾

Report date: 2023/03/03 09:37:40
NME

Base Information

Drug NameBenzylpenicillin Potassium
Drug Alias Namebenzylpenicillinum青霉素G钾Penicillin G potassiumbencilpenicilinaPfizerpen
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsPericarditisEndocarditisMeningitis +[24] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryCanada
Original Approved Date1951/12/31
Country/TerritoryCanadaUnited StatesUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUganda Heart Institute, Kampala, UgandaMeiji Seika PharmaBaxter Hlthcare +[5] 
Inactive CompaniesAyerst Laboratories Division of Wyeth-Ayerst Pharmaceuticals Inc
Active IndicationsPericarditisEndocarditisMeningitis +[24] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01CE01S01AA14
Related LinksWikipediaDrugBankKEGG